Sangamo Therapeutics, Inc (SGMO): 8-K filed Aug 12, 2026

Form type

8-K

Filing date

Aug 12, 2026

Accession number

0001193125-26-346796

Filer

Sangamo Therapeutics, Inc (CIK 1001233)